Intravenous recombinant tissue plasminogen activator therapy for ischemic stroke patients over 80 years old: a propensity score matched analysis from the Fukuoka Stroke Registry

被引:0
|
作者
Matsuo, R. [1 ]
Kamouchi, M. [1 ]
Hata, J. [1 ]
Wakisaka, Y. [1 ]
Kuroda, J. [1 ]
Ago, T. [1 ]
Kitazono, T. [1 ]
机构
[1] Kyushu Univ, Fukuoka 812, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:149 / 149
页数:1
相关论文
共 50 条
  • [1] Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
    Matsuo, Ryu
    Kamouchi, Masahiro
    Fukuda, Haruhisa
    Hata, Jun
    Wakisaka, Yoshinobu
    Kuroda, Junya
    Ago, Tetsuro
    Kitazono, Takanari
    PLOS ONE, 2014, 9 (10):
  • [2] Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry
    Matsuo, Ryu
    Kamouchi, Masahiro
    Ago, Tetsuro
    Hata, Jun
    Shono, Yuji
    Kuroda, Junya
    Wakisaka, Yoshinobu
    Sugimori, Hiroshi
    Kitazono, Takanari
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2014, 14 (04) : 954 - 959
  • [3] Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years
    Mione, Gioia
    Ducrocq, Xavier
    Thilly, Nathalie
    Lacour, Jean-Christophe
    Vespignani, Herve
    Richard, Sebastien
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2016, 16 (07) : 843 - 849
  • [4] Efficacy of Intravenous Thrombolysis with Tissue Plasminogen Activator in Elderly Patients with Acute Ischemic Stroke: Fukuoka Stroke Registry (FSR)
    Matsuo, Ryu
    Kamouchi, Masahiro
    Ago, Tetsuro
    Kuroda, Junya
    Kuwashiro, Takahiro
    Sugimori, Hiroshi
    Kitazono, Takanari
    CEREBROVASCULAR DISEASES, 2012, 34 : 53 - 53
  • [5] Prognosis in Mild or Rapidly Improving Ischemic Stroke Not Treated With Recombinant Tissue Plasminogen Activator: Fukuoka Stroke Registry
    Sakai, Shota
    Osaki, Masato
    Kimura, Shunsuke
    Hidaka, Masaoki
    Arakawa, Shuji
    Ago, Tetsuro
    Matsuo, Ryu
    Kamouchi, Masahiro
    Kitazono, Takanari
    STROKE, 2018, 49
  • [6] Prognosis in Mild or Rapidly Improving Ischemic Stroke Not Treated with Recombinant Tissue Plasminogen Activator: Fukuoka Stroke Registry
    Sakai, Shota
    Osaki, Masato
    Kimura, Shunsuke
    Hidaka, Masaoki
    Arakawa, Shuji
    Ago, Tetsuro
    Matsuo, Ryu
    Kamouchi, Masahiro
    Kitazono, Takanari
    CEREBROVASCULAR DISEASES, 2017, 44 : 41 - 41
  • [7] Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: Propensity score analysis
    Zaidat, OO
    Welter, E
    Love, TE
    Tarr, RW
    Sunshine, JL
    Landis, DMD
    Selman, WR
    Enterline, DS
    Smith, TP
    Alexander, MJ
    JOURNAL OF NEUROSURGERY, 2004, 100 (01) : A181 - A181
  • [8] Intravenous tissue plasminogen activator for acute ischemic stroke in patients ≥80 years old:: The London, Canada experience
    Demaerschalk, B
    Merino, JG
    Silver, B
    Tamayo, A
    Wong, EH
    Devasenapathy, A
    O'Callaghan, C
    Kertesz, A
    Young, GB
    Spence, JD
    Hachinski, V
    STROKE, 2001, 32 (01) : 368 - 369
  • [9] Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis
    Anaissie, James E.
    Monlezun, Dominique J.
    Siegler, James E.
    Waring, Elizabeth D.
    Dowell, Lauren N.
    Samai, Alyana A.
    George, Alexander J.
    Kimbrough, Tara
    Berthaud, Jimmy
    Martin-Schild, Sheryl
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (11): : 2603 - 2609
  • [10] Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients
    Chen, Yan
    Li, Chen-hua
    Wang, Yu-Xin
    Zhang, Chen-Hao
    Dong, Zhong
    Zhang, Fang-fang
    Wang, Jin-Huan
    Zhang, Pei-Lan
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (03) : 883 - 888